WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

ORAL CANDIDIASIS: A REVIEW

Dr. Chandrashekhar R. Parkarwar, Dr. Sayyed Mohammed Qadri, Dr. Saudagar Mohd. Ziauddin, Dr. Nilofar Zaidi, Dr. Lata Kale, HOD, Dr. Vaibhav Lav Pansambal, Dr. Pratik C. Parkarwar*, Dr. Sagar Khairnar, Dr. Usama Kharaidi, Dr. Prashant Kore, Dr. Pooja Muley and Dr.Pravin. Gaikwad

ABSTRACT

Candidiasis is a universal opportunistic fungal infection of the oral cavity which may be a reason of distress in dental patients. The article reviews common clinical types of candidiasis, its diagnosis, current treatment modalities with stress on the role of deterrence of repetition in the susceptible dental patient. The dental hygienist can play a vital role in education of patients to avoid recurrence. The incidence of invasive fungal infections (IFIs) has amplified over the last decade with the ascend in atâ€Ârisk populations of patients. The morbidity and mortality of IFIs are high and management of these conditions is a great dare. With the extensive adoption of antifungal prophylaxis, the epidemiology of invasive fungal pathogens has altered. Oral candidiasis is a familiar fungal infection in patients with an impaired immune system, such as those undergoing chemotherapy for cancer and patients with AIDS.The systemic azoles, ketoconazole, fluconazole and itraconazole, have been a main advantage in treatment. To date, confrontation has mainly been a problem with fluconazole in AIDS. However, it is important that measures are instituted to prevent the spread of defiant strains and the development of cross resistance.

Keywords: Candidiasis, Opportunistic, CD4, Azole, IFI.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More